This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 23-29 April 2023 and includes updates on cholera, avian influenza, COVID-19, invasive meningococcal disease, influenza, Marburg virus disease, and the seizure of a reference laboratory by an armed group.
This document presents the estimated incidence of bloodstream infections (BSI) with three key antibiotic-resistant bacteria, at country level in EU/EEA countries, using public data sources.
Infection with Salmonella spp. is the second most reported zoonotic disease in humans with 60 050 reported cases in 2021 in the European Union (EU) and Salmonella is associated with the highest number of foodborne outbreaks. The overall EU trend of salmonellosis incidence for the years 2017 to 2021 have not changed significantly. To prevent foodborne diseases such as salmonellosis, human surveillance systems at different levels are essential to monitor the disease and to have an early detection and response to outbreaks.
Since June 2017, a persistent cross-border outbreak of Salmonella Virchow ST16 has been ongoing in five EU/EEA countries, the UK, and the US, according to a Rapid Outbreak Assessment released by ECDC and EFSA today.
Since June 2017, a cross-border outbreak of Salmonella Virchow ST16 has been ongoing in five EU/EEA countries, the UK, and the US. A total of 210 cases have been reported. No deaths have been reported. A majority of cases have been linked to local restaurants serving kebab meat.
Resistance of Salmonella and Campylobacter to commonly used antimicrobials is frequently observed in humans and animals, reveals a report by the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA).
This report provides an overview of the main findings of the 2020–2021 harmonised AMR monitoring in Salmonella spp., Campylobacter jejuni and C. coli in humans and food-producing animals and relevant meat thereof.
Immediate health needs following earthquakes in Türkiye and Syria are mostly related to trauma and the disruption of healthcare, however, infectious disease threats may be concerning in the following two to four weeks.
Increased numbers of shigellosis cases, mainly caused by Shigella sonnei, among travellers returning from Cabo Verde, have been reported in the EU/EEA, the United Kingdom (UK) and the United States (US) since September 2022.
An increased reporting of shigellosis cases, mainly caused by Shigella sonnei, among travellers returning from Cabo Verde has been ongoing in the European Union/European Economic Area (EU/EEA), the United Kingdom (UK), and the United States (US) since September 2022. This outbreak evolved rapidly during November and December 2022.